Is colon cancer management in a comprehensive cancer centre evidence-based?

Colorectal Disease

Volumn 1, Issue 4, 1999, Pages 207-213

  Ray Coquard, I ^a,d   Philip, T ^a   Negrier S ^b   Desseigne, F ^b   Rivoire, M ^b   Fervers, B ^c   Farsi, F ^a   Chauvin, F ^a  

^a CENTRE LÉON BÉRARD   (France)

^b Digest Comity Ctr Leon Berard

^c Fed Natl des Centres de Lutte C   (France)

^d NONE   (France)

Author keywords

Colon cancer; Evidence based medicine; Guidelines; Medical decision

Indexed keywords

EID: 0006443920     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.1999.00046.x     Document Type: Article

References (32)

1. Institute of Medicine (1990) Clinical Practice Guidelines: Directions for a New Program (eds Field MJ, Lohr KN) p. 38. National Academy Press, Washington, DC.
2. Grimshaw JM, Russel TI. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluation. Lancet 1993; 342: 1317-22.
3. Woolf SH. Practices guidelines: a new reality in medicine. III. Impact of patient care. Arch Intern Med 1993; 153: 2646-55.
4. Grilli R, Lomas J. Evaluating the message: the relationship between compliance rate and the subject of a practice guideline. Med Care 1994; 32: 202-13.
5. Eddy DM. The individual vs. society: is there a conflict? JAMA 1991; 265: 1446-50.
6. Eddy DM. Guidelines for policy statements: the explicit approach. JAMA 1990; 263: 2239-43.
7. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992; 326: 1097-101.
8. Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health 1984; 74: 979-83.
9. Woolf SH. Practices guidelines: a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992; 152: 946-52.
10. Ray-Coquard I, Philip T, Lehmann M et al. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center. JAMA 1997; 278: 1591-5.
11. Canadian Medical Association (1994) Guidelines for Canadian Clinical Practice Guidelines. Canadian Medical Association, Ottawa.
12. Ellis J, Mulligan I, Rowe J, Sackett DL. Inpatient general medicine is evidence based. Lancet 1995; 346: 407-10.
13. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95: 2S-4S.
14. Donabedian A (1982) The Criteria and Standards of Quality, Vol. 2: Explorations in Quality Assessment and Monitoring. Health Administration Press, Ann Arbor, MI.
15. Asler VB, Coller FA. The prognostic significance of direct extension of cancer of the colon and rectum. Ann Surg 1954; 139: 846-52.
16. Wolmark N, Rockette N, Fisher B et al. The benefit of lecoverin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993; 11: 1879-87.
17. Rougier P, Paillot B, Laplanche A et al. End results of a multicentric randomized trial comparing 5 FU in continuous systemic infusion to bolus administration in measurable metastatic colorectal cancer. Proc Am Soc Clin Oncol 1992; 111: 63 (Abstr.).
18. Budd GT, Fleming TR, Budkowski RM et al. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A southwest Oncology Group Study. J Clin Oncol 1987; 5: 272-7.
19. Moertel CG, Fleming TR, Macdonald JS et al. Levamizol and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
20. Zaniboni A, Elichman C, Seitz JF et al. FUFA increases disease-free survival (DFS) in resected B2C colon cancer (CC): results of prospective pooled analysis of 3 randomized trials (RCTs). Proc Am Soc Clin Oncol 1993; 12: 191 (Abstr.).
21. Rougier P, Laplanche A, Huguier CM et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-8.
22. Scheithauer W, Rosen H, Kornek GV et al. Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 1993; 306: 752-5.
23. Jakesz R, Stege G. Primary (preoperative, neoadjuvant) chemotherapy of colon cancer: a therapeutic alternative? Chirurg 1994; 65: 497-502.
24. Coburn MC, Pricolo VE, Soderberg CH. Factors affecting prognosis and management of carcinoma of the colon and rectum in patients more than eighty years of age. J Am Coll Surg 1994; 179: 65-69.
25. Hugues K, Foster J. The role of adjuvant chemotherapy following curative hepatic resection of colo-rectal metastases. Proc Am Soc Clin Oncol 1991; 10: 145 (Abstr.).
26. Bekrada M, Culine S, Mathieu-Boue A et al. Etude de phase II du CPT 11 en première ligne dans les cancers colorectaux métastatiques: résultats préliminaires. Bull Cancer 1994; 6: 562-3.
27. Alle PE, Tepper JE, Gunderson LL, Munzenrider JE. Postoperative radiation therapy for incompletely resected carcinoma. Int J Radiation Oncol Biol Phys 1989; 17: 1171-6.
28. Sherman DM, Weichselbaum DM, Order SE, Cloud L, Trey C, Piro AJ. Palliation of hepatic metastases. Cancer 1978; 41: 2013-7.
29. Livraghi T, Claudio V, Lazzaroni S. Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiol 1990; 179: 709-12.
30. Federation Nationale des Centres Lutte Contre le Cancer (1995) Standards, Options, Recommandations Pour la Prise En Charge Des Patients Atteints de Cancer Du Côlon. pp. 110-26. Arnette Blackwell SA, Paris.
31. Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 1995; 13: 1904-11.
32. Greenberg ER, Chute CG, Stukel T et al. Social and economical factors in the choice of lung treatment. N Engl J Med 1988; 318: 612-7.